199 related articles for article (PubMed ID: 17535866)
1. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
Nielsen LB; Ploug KB; Swift P; Ørskov C; Jansen-Olesen I; Chiarelli F; Holst JJ; Hougaard P; Pörksen S; Holl R; de Beaufort C; Gammeltoft S; Rorsman P; Mortensen HB; Hansen L;
Eur J Endocrinol; 2007 Jun; 156(6):663-71. PubMed ID: 17535866
[TBL] [Abstract][Full Text] [Related]
2. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
Pörksen S; Nielsen LB; Kaas A; Kocova M; Chiarelli F; Orskov C; Holst JJ; Ploug KB; Hougaard P; Hansen L; Mortensen HB;
J Clin Endocrinol Metab; 2007 Aug; 92(8):2910-6. PubMed ID: 17519307
[TBL] [Abstract][Full Text] [Related]
3. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
Moritz W; Leech CA; Ferrer J; Habener JF
Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
[TBL] [Abstract][Full Text] [Related]
4. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism.
Light PE; Manning Fox JE; Riedel MJ; Wheeler MB
Mol Endocrinol; 2002 Sep; 16(9):2135-44. PubMed ID: 12198249
[TBL] [Abstract][Full Text] [Related]
6. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
[TBL] [Abstract][Full Text] [Related]
7. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
8. Immuno-localization of sulphonylurea receptor 1 in rat pancreas.
Suzuki M; Fujikura K; Kotake K; Inagaki N; Seino S; Takata K
Diabetologia; 1999 Oct; 42(10):1204-11. PubMed ID: 10525661
[TBL] [Abstract][Full Text] [Related]
9. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility.
Miki T; Minami K; Shinozaki H; Matsumura K; Saraya A; Ikeda H; Yamada Y; Holst JJ; Seino S
Diabetes; 2005 Apr; 54(4):1056-63. PubMed ID: 15793244
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
Rafiq M; Flanagan SE; Patch AM; Shields BM; Ellard S; Hattersley AT;
Diabetes Care; 2008 Feb; 31(2):204-9. PubMed ID: 18025408
[TBL] [Abstract][Full Text] [Related]
12. Gastric inhibitory polypeptide is the major insulinotropic factor in K(ATP) null mice.
Tsukiyama K; Yamada Y; Miyawaki K; Hamasaki A; Nagashima K; Hosokawa M; Fujimoto S; Takahashi A; Toyoda K; Toyokuni S; Oiso Y; Seino Y
Eur J Endocrinol; 2004 Sep; 151(3):407-12. PubMed ID: 15362972
[TBL] [Abstract][Full Text] [Related]
13. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
[TBL] [Abstract][Full Text] [Related]
14. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
15. Carriers of an inactivating beta-cell ATP-sensitive K(+) channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
Huopio H; Vauhkonen I; Komulainen J; Niskanen L; Otonkoski T; Laakso M
Diabetes Care; 2002 Jan; 25(1):101-6. PubMed ID: 11772909
[TBL] [Abstract][Full Text] [Related]
16. An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action.
Schmid D; Stolzlechner M; Sorgner A; Bentele C; Assinger A; Chiba P; Moeslinger T
Cell Mol Life Sci; 2012 Jan; 69(1):129-48. PubMed ID: 21671119
[TBL] [Abstract][Full Text] [Related]
17. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
[TBL] [Abstract][Full Text] [Related]
18. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
19. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
Babenko AP
J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
[TBL] [Abstract][Full Text] [Related]
20. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
